Releasing agent: Difference between revisions
>Josikins m Text replacement - " | https://www.ncbi." to " (PubMed.gov / NCBI) | https://www.ncbi." |
>Kaylee No edit summary |
||
Line 1: | Line 1: | ||
A '''releasing agent''' | A '''releasing agent''' is a drug that induces the release of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission. Many drugs use neurotransmitter release to exert their psychological and physiological effects, namely the [[amphetamines]] and related compounds. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters. | ||
==Mechanism of Action== | ==Mechanism of Action== |